Search

Search Constraints

You searched for: Author/Creator Chern, B.

Search Results

3. Long‐term safety of monthly zoledronic acid therapy beyond 1 year in patients with advanced cancer involving bone (LoTESS): A multicentre prospective phase 4 study. (30th January 2017)